RNA sequencing enables clinically relevant molecular classification and reclassification of endometrial stromal sarcomas to guide therapeutic strategy.
May support RNAseq reclassification of endometrial stromal sarcomas; leaves open prospective validation before guiding therapy.
gene mutations. RNAseq brings clinically relevant molecular classification, enabling the reclassification of diseases and the guidance of therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Brahmi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: